Skip to main content
. 2019 Apr 10;17(2):117–127. doi: 10.1176/appi.focus.20180037

TABLE 1.

Recommended screening tests and interventions for specific substances used on college campuses

Substance High-risk population Screening Brief interventions Treatment recommendations
Alcohol Fraternity and sorority membership, students who used heavily in high school CRAFFT (for adolescents; car, relax, alone, forget, friends, trouble), CAGE Questionnaire (cut down, annoyed, guilty, eye opener), AUDIT (Alcohol Use Disorders Identification Test), TAPS Tool (tobacco, alcohol, prescription medication and other substance use), NM ASSIST (NIDA-Modified Alcohol, Smoking and Substance Involvement Screening Test) BASICS Program; College Drinker's Check-up (CDCU); motivational interviewing to address discrepancy between problematic use and values and to assess readiness for change Detoxification when withdrawal symptoms are present; referral for individual therapy, self-help groups, or pharmacotherapy (i.e., naltrexone or acamprosate) for alcohol use disorders; close monitoring around academic performance and necessary accommodations
Tobacco, nicotine Fraternity and sorority membership, existing mental health difficulties NM ASSIST Motivational interviewing to address discrepancy between problematic use and values and to assess readiness for change Nicotine replacement therapy; no evidence that vaporizing devices lead to reduced risk of relapse (may escalate use); behavioral therapy referral
Stimulants Academic difficulties, preexisting ADHD, midterms DAST (Drug Abuse Screening Test), TAPS Tool, NM ASSIST Motivational interviewing to address discrepancy between problematic use and values and to assess readiness for change; warn of risk of using cocaine with alcohol. No evidenced-based pharmacological intervention at this time; balance risk of prescribing stimulants with need, if indicated; cognitive-behavioral therapy and 12-step programming may be helpful; close monitoring of academic performance and necessary accommodations
Opioids Withdrawal from social interactions, poor academic performance, existing mental health difficulties DAST, TAPS Tool, NM ASSIST Motivational interviewing not advised; thoroughly assess for signs of withdrawal and acute safety concerns Significant risk of overdose; consider detoxification setting or residential treatment setting for regular use; buprenorphine-naloxone and long-acting injectable naltrexone are considered first-line treatment; close monitoring of academic performance and necessary accommodations
Marijuana, cannabis Low perception of harm of marijuana use, peers who use, poor academic performance, existing mental health concerns World Health Organization ASSIST (Alcohol, Smoking and Substance Involvement Screening Test), how many times have you used marijuana in the past 90 days, TAPS Tool, NM ASSIST Motivational interviewing to address discrepancy between problematic use and values and to assess readiness for change; marijuana eCHECKUP TO GO N-acetylcysteine 1,200 mg twice daily may reduce cravings and risk of relapse among motivated individuals up to age 21 in addition to contingency management; behavioral therapy referral; close monitoring of academic performance and necessary accommodations
Hallucinogens Frequent attendance at “rave parties” or club settings DAST, TAPS Tool, NM ASSIST Motivational interviewing to address discrepancy between problematic use and values and to assess readiness for change; provide information about potential risks of “microdosing” (21) Inform of risk of tolerance formation after only one use, as well as flashbacks; develop a plan for abstinence or reduction; referral for individual therapy
Benzodiazepines Existing mental health difficulties, combining benzodiazepines and alcohol in party setting DAST, TAPS Tool, NM ASSIST Motivational interviewing to address discrepancy between problematic use and values and to assess readiness for change; provide psychoeducation about dangers of using benzodiazepines in combination with alcohol and other substances Assess for withdrawal symptoms and consider detoxification if present, followed by residential treatment or long-term program; outpatient management is not recommended unless use is infrequent
Inhalants Existing mental health difficulties, expressed need for escape and dissociation DAST, NM ASSIST Provide psychoeducation about the acute and long-term dangers of use Significant health concerns and risk with acute intoxication; long-term use can lead to depression and brain damage; consider higher level of care, such as inpatient or partial program.
Over-the-counter medications (dextromethorphan, antihistamines) Existing mental health difficulties, expressed need for escape and dissociation DAST Motivational interviewing to address discrepancy between problematic use and values and to assess readiness for change Risk of significant impairment from acute intoxication; inpatient hospitalization for any accompanying suicidality, paranoia, or persistent hallucinations.